Top-News
Donnerstag,
15.05.2014 11:36
von
PR Newswire
| Aufrufe: 59
TROPONIN I RAPID DIAGNOSTIC TEST
Eine Tageszeitung (Symbolbild).
pixabay.com
PR Newswire
ANAHEIM, Calif., May 15, 2014
ANAHEIM, Calif., May 15, 2014 /PRNewswire-iReach/ -- Headquartered in Anaheim, California, WholeHealth Products. (OTC: GWPC) is a diversified company comprised of several specialized partners focused on leveraging the power and convenience of advanced technology and the proven expertise of its team of professionals to improve the fundamental business of health and wellness. WholeHealth Products' line of more than 10 professional diagnostic tests for hospitals, doctors, clinics and healthcare centers, and its more than 8 retail consumer tests is proud to announce an addition to its line of rapid diagnostic tests.
WholeHealth Products announces the release of the FDA Cleared "Troponin I" rapid test.
This is a remarkable breakthrough in the health of heart patients and patients needing blood thinners.
The troponin test is used to help diagnose a heart attack, stroke, TIA's, blood thinning/clotting, determining if the heart is ok for blood thinning medications, to detect and evaluate mild to severe heart injury, and to distinguish chest pain that may be due to other causes. In those who experience heart-related chest pain, discomfort, or other symptoms and do not seek medical attention for a day or more, the troponin test will still be positive if the symptoms are due to heart damage.
Inspired by its slogan, "Love Life Live Long," WholeHealth is committed to building long term relationships with the medical and healthcare professional and the patients, helping saves lives.
WHOLEHEALTH PRODUCTS INC., YOUR PARTNER IN THE BUSINESS OF HEALTH AND WELLNESS.
Certain information set forth in this fact sheet may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of WholeHealth Products Inc, including, but not limited to, risks associated with the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and the uncertainty of obtaining additional financing. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.
Media Contact: CHARLES STRONGO, WHOLEHEALTH PRODUCTS INC, 1-944-946-5343, ADMIN@WHOLEHEALTH-PRODUCTS.COM
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE WholeHealth Products
Werbung
Mehr Nachrichten zur WHOLEHEALTH PRODUCTS Aktie kostenlos abonnieren
E-Mail-Adresse
Bitte überprüfe deine die E-Mail-Adresse.
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)
-1
Vielen Dank, dass du dich für unseren Newsletter angemeldet hast. Du erhältst in Kürze eine E-Mail mit einem Aktivierungslink.
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.
Andere Nutzer interessierten sich auch für folgende News
19.04.24 - PR Newswire
